News & Updates

Show Multimedia Only

Should IBD patients avoid prescription NSAIDs?

19 Feb 2026 by

Despite the reported adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs) in individuals with inflammatory bowel disease (IBD), a study presented at Crohn’s and Colitis Congress 2026 appears to show otherwise.

Should IBD patients avoid prescription NSAIDs?

19 Feb 2026

Dapagliflozin minimally beneficial for reducing AF recurrence postablation

19 Feb 2026

Treatment with dapagliflozin for 3 months falls short of reducing early recurrence of arrhythmia in patients with persistent atrial fibrillation (AF) who have undergone catheter ablation, according to the DARE-AF* trial.

Dapagliflozin minimally beneficial for reducing AF recurrence postablation

19 Feb 2026

Novel neuroprotectant loberamisal boosts functional recovery after stroke

19 Feb 2026 by

In patients with acute ischaemic stroke, administration of loberamisal, a novel neuroprotective agent, within 48 hours of symptom onset improves functional outcomes, according to the LAIS* trial presented at ISC 2026.

Novel neuroprotectant loberamisal boosts functional recovery after stroke

19 Feb 2026

Oral FXIa inhibitor reduces stroke recurrence without increasing major bleeding events

18 Feb 2026 by

The oral factor XIa (FXIa) inhibitor asundexian scores high for secondary prevention in patients with non-cardioembolic stroke or high-risk transient ischaemic attack (TIA) who are receiving standard antiplatelet therapy, having met its primary efficacy and safety endpoints in the phase III OCEANIC-STROKE trial.

Oral FXIa inhibitor reduces stroke recurrence without increasing major bleeding events

18 Feb 2026

Pharmacist support in CGM initiation helps lower A1c in patients with diabetes

18 Feb 2026

Clinical pharmacists can help reduce the level of glycated haemoglobin (A1c) in patients with diabetes by assisting them with the initiation of continuous glucose monitoring (CGM), through education, and follow-up, according to a study.

Pharmacist support in CGM initiation helps lower A1c in patients with diabetes

18 Feb 2026

Metyrapone confers BP-lowering benefit in mild autonomous cortisol secretion

18 Feb 2026

Taking metyrapone in the evening results in significant reductions in systolic and diastolic blood pressure without causing adrenal insufficiency in patients with mild autonomous cortisol secretion, according to a retrospective study.

Metyrapone confers BP-lowering benefit in mild autonomous cortisol secretion

18 Feb 2026

Metformin disappoints in peripheral artery disease

17 Feb 2026

Treatment with metformin does not appear to improve the walking ability of patients with peripheral artery disease (PAD) but no diabetes, according to a study.

Metformin disappoints in peripheral artery disease

17 Feb 2026

Upadacitinib stays effective for 1 year in real-world UC patients

16 Feb 2026 by

Treatment with upadacitinib appears to yield high and durable remission rates in patients with ulcerative colitis (UC), according to 1-year data from a real-world study.

Upadacitinib stays effective for 1 year in real-world UC patients

16 Feb 2026

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

16 Feb 2026

A 15-year study recommends taking into consideration the differential risks of hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivations when choosing targeted therapies for the treatment of psoriasis and psoriatic arthritis (PsA), particularly in patients with risk factors for viral reactivation.

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

16 Feb 2026

GLP-1 RAs may lower long-term mortality risk in AIS patients

16 Feb 2026 by

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) appears to contribute to a long-term reduced risk of death in patients with acute ischaemic stroke (AIS), suggests a study. However, less than 1 percent of these individuals have been prescribed GLP-1 RAs upon discharge.

GLP-1 RAs may lower long-term mortality risk in AIS patients

16 Feb 2026

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Should IBD patients avoid prescription NSAIDs?

Should IBD patients avoid prescription NSAIDs?

Dapagliflozin minimally beneficial for reducing AF recurrence postablation

Dapagliflozin minimally beneficial for reducing AF recurrence postablation

Novel neuroprotectant loberamisal boosts functional recovery after stroke

Novel neuroprotectant loberamisal boosts functional recovery after stroke

Oral FXIa inhibitor reduces stroke recurrence without increasing major bleeding events

Oral FXIa inhibitor reduces stroke recurrence without increasing major bleeding events

Pharmacist support in CGM initiation helps lower A1c in patients with diabetes

Pharmacist support in CGM initiation helps lower A1c in patients with diabetes

Metyrapone confers BP-lowering benefit in mild autonomous cortisol secretion

Metyrapone confers BP-lowering benefit in mild autonomous cortisol secretion

Metformin disappoints in peripheral artery disease

Metformin disappoints in peripheral artery disease

Upadacitinib stays effective for 1 year in real-world UC patients

Upadacitinib stays effective for 1 year in real-world UC patients

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

GLP-1 RAs may lower long-term mortality risk in AIS patients

GLP-1 RAs may lower long-term mortality risk in AIS patients